Luye Pharma Group Ltd. (HKG: 2186)

Luye Pharma Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	11,285	14,031	12,992	12,607	11,729	19,091
Market Cap Growth	-18.43%	8.00%	3.05%	7.49%	-38.56%	7.12%
Enterprise Value	15,624	17,078	18,013	16,610	16,596	21,869
Last Close Price	3.00	3.73	3.66	3.56	3.61	5.77
PE Ratio	13.63	23.70	18.63	-74.36	13.74	11.90
PS Ratio	1.66	2.07	1.92	1.98	1.78	2.68
PB Ratio	0.81	0.94	1.04	1.13	1.22	1.91
P/FCF Ratio	-	13.23	11.51	-27.47	28.99	40.32
P/OCF Ratio	-	7.98	6.95	56.32	9.56	12.00
EV/Sales Ratio	2.30	2.52	2.66	2.60	2.52	3.07
EV/EBITDA Ratio	7.25	9.98	11.18	14.92	9.52	9.67
EV/EBIT Ratio	10.98	17.47	20.19	37.24	14.14	12.26
EV/FCF Ratio	-	16.10	15.96	-36.20	41.02	46.18
Debt / Equity Ratio	0.67	0.62	0.82	1.04	1.23	0.96
Debt / EBITDA Ratio	4.72	5.33	6.27	10.09	6.68	4.18
Debt / FCF Ratio	-	8.75	9.12	-25.39	29.30	20.20
Asset Turnover	0.24	0.25	0.26	0.24	0.28	0.34
Inventory Turnover	2.44	2.42	2.42	2.65	2.52	2.46
Quick Ratio	0.93	1.08	0.83	1.08	1.00	1.02
Current Ratio	1.28	1.32	1.14	1.42	1.38	1.67
Return on Equity (ROE)	6.33%	4.39%	5.79%	-1.68%	8.26%	16.07%
Return on Assets (ROA)	3.09%	2.23%	2.11%	1.05%	3.09%	5.39%
Return on Capital (ROIC)	3.63%	2.63%	2.55%	1.24%	3.48%	6.32%
Earnings Yield	7.34%	4.18%	5.26%	-1.31%	7.15%	8.18%
FCF Yield	7.56%	8.69%	-3.64%	3.45%	2.48%
Dividend Yield	0.00%	-	-	-	-	2.19%
Payout Ratio	0.00%	-	-	-	24.84%	26.99%
Buyback Yield / Dilution	-4.81%	-7.11%	-1.03%	-7.87%	0.85%	0.01%
Total Shareholder Return	-4.81%	-7.11%	-1.03%	-7.87%	0.85%	2.20%

Source: S&P Capital IQ. Standard template. Financial Sources.